Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori

Clicks: 241
ID: 118653
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Introduction: Clarithromycin (CAM)-based triple therapy comprising proton pump inhibitors and amoxicillin is administered as first-line eradication treatment against Helicobacter pylori infection. However, the eradication rate achieved with CAM-based triple therapy has decreased to H. pylori eradication. Methods:H. pylori-positive patients were tre
Reference Key
adachi2017oncologycomparative Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Teppei Adachi;Shigenaga Matsui;Tomohiro Watanabe;Kazuki Okamoto;Ayana Okamoto;Masashi Kono;Mitsunari Yamada;Tomoyuki Nagai;Yoriaki Komeda;Kosuke Minaga;Ken Kamata;Kentaro Yamao;Mamoru Takenaka;Yutaka Asakuma;Toshiharu Sakurai;Naoshi Nishida;Hiroshi Kashida;Masatoshi Kudo;
Journal oncology
Year 2017
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.